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Abstract
Human T-lymphotropic virus 1 (HTLV-1) is transmitted directly between cells via an organized cell-cell contact called a
virological synapse (VS) [1,2]. The VS has been studied by light microscopy, but the ultrastructure of the VS and the nature of
the transmitted viral particle have remained unknown. Cell-free enveloped virions of HTLV-1 are undetectable in the serum
of individuals infected with the human T-lymphotropic virus 1 (HTLV-1) and during in vitro culture of naturally infected
lymphocytes. However, the viral envelope protein is required for infectivity of HTLV-1, suggesting that complete, enveloped
HTLV-1 virions are transferred across the synapse. Here, we use electron tomography combined with immunostaining of
viral protein to demonstrate the presence of enveloped HTLV-1 particles within the VS formed between naturally infected
lymphocytes. We show in 3D that HTLV-1 particles can be detected in multiple synaptic clefts at different locations
simultaneously within the same VS. The synaptic clefts are surrounded by the tightly apposed plasma membranes of the
two cells. HTLV-1 virions can contact the recipient cell membrane before detaching from the infected cell. The results show
that the HTLV-1 virological synapse that forms spontaneously between lymphocytes of HTLV-1 infected individuals allows
direct cell-cell transmission of the virus by triggered, directional release of enveloped HTLV-1 particles into confined
intercellular spaces.
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Introduction
Human T cell Lymphotropic Virus 1 (HTLV-1) is a complex
retrovirus that causes Adult T cell Leukaemia/Lymphoma (ATL)
[3] in 2–3% and several chronic inflammatory diseases in another
2–3% of infected people [4–7]. The main host cells infected by
HTLV-1 in vivo are CD4
+ and CD8
+ T cells [5,8–10]. Cell-cell
contact is required for efficient transmission of HTLV-1, both
within and between individuals [11,12] and the virus is transmitted
through an organized cell-cell contact termed the virological
synapse (VS) [2]. The VS has a peripheral adhesion domain and
one or several central transmission domains, similar to the
adhesive peripheral supramolecular activation cluster (pSMAC)
and the signalling central supramolecular activation cluster
(cSMAC) in the immunological synapse (IS) [13]. Upon cell-cell
contact between an HTLV-1-infected cell and a target cell, the
virus induces a prolonged and strong adhesion. Expression of the
viral transcriptional transactivator protein Tax and engagement of
the cell adhesion molecule ICAM-1 cause the polarization of the
microtubule organizing centre (MTOC) of the infected cell
towards the cell-cell contact [14,15]. The transport of viral
material towards the VS and into the recipient cell requires the
integrity of the microtubule cytoskeleton [2]. The HTLV-1 surface
glycoprotein Env is required for infectivity [12,16], suggesting that
enveloped virions are transmitted between cells across the VS.
However, HTLV-1 is typically undetectable in the serum of
infected individuals by RT-PCR, and the apparent lack of
extracellular virions has precluded detailed study of transmission
from naturally infected cells. To identify the mode of viral
transmission in the HTLV-1 VS we examined the ultrastructure of
the VS using electron tomography of immunostained conjugates
formed between CD4
+ T cells from HTLV-1-infected individuals
and conjugates between MS9 cells (a chronically HTLV-1-infected
cell line) and Jurkat cells. The results reveal the ultrastructure of
the HTLV-1 virological synapse and reconcile the requirement for
cell contact and HTLV-1-Env protein for HTLV-1 infectivity with
the lack of detection of cell-free virions in the serum.
Results
Two dimensional ultrastructure of HTLV-1 Virological
synapse
To identify the mode of viral transmission in the HTLV-1 VS we
examined the ultrastructure of the VS using electron tomography
of cell-cell conjugates spontaneously formed either between
autologous CD4
+ T cells isolated from the PBMCs of HTLV-1-
PLoS ONE | www.plosone.org 1 May 2008 | Volume 3 | Issue 5 | e2251infected HAM/TSP individuals with high proviral load or between
MS9 cells (a chronically HTLV-1-infected cell line), as a donor T-
cell, and the Jurkat cell line, as a target T-cell. The use of electron
tomography permits the reconstruction of a 3D image [17] from
transmission electron micrographs of successive sections through
the depth of a sample preparation. The cell-cell conjugate
preparation was carried out under strict biosafety conditions. To
preserve the cell integrity and the immediate environment of the
cell-cell conjugates we used a chemical fixation protocol in which
the cells were subjected to two steps of treatment: a short and gentle
fixation ‘‘in situ’’ with a buffer solution containing paraformalde-
hyde (PFA) and glutaraldehyde, immediately followed by a second
fixation for a longer time (see Materials and Methods section).
Finally, the samples were post-fixed with osmium tetroxide and
embedded in resin. In order to detect HTLV-1 virions at the VS,
certain samples were stained with an antibody against the HTLV-1
Gag p19 matrix protein before embedding. Tilt series of 200–
300 nm thick sections were recorded with an FEI Tecnai F30
transmission-electron microscope (300 kV) on a 2k62k Gatan
CCD camera at low magnification (,10k) to capture the whole
synapse and tomographic reconstructions were calculated using the
software IMOD [18]. The tomographic data have been deposited
in the Macromolecular Structure Database of the European
Bioinformatics Institute (unique accession code EMD-1426).
We analysed a large number of randomly recorded low-
magnification EM data sets of HTLV-1-infected (Figure 1A) and
uninfected (Figure 1B) CD4
+ T cells. The formation of cell-cell
conjugates was significantly more frequent among HTLV-1
infected CD4
+ T cells (2.8% conjugates in a total of 1084 cells)
than in samples with non-infected CD4
+ T cells (0.8% conjugates
in 619 cells) (x
2=6.58 with Yates’ correction; two-tailed P=0.02).
MS9 (HTLV-1-producing) cells were distinguished from uninfect-
ed (Jurkat) cells by the smaller diameter, the more uniform
morphology and the better preserved intracellular structures in
Jurkat cells. In conjugates formed among fresh PBMCs, infected
cells were identified by positive staining for HTLV-1 Gag protein.
The 2D measured length of the cell-cell contacts was greater in
conjugates between HTLV-1 infected CD4
+ T cells (mean,
2.8 mm; max., 5.6 mm) than in normal CD4
+ T cell conjugates
(mean, 1.9 mm; max., 2.5 mm) (Figure 1C). In a sample of 1084
CD4
+ T cells stained for HTLV-1 Gag protein we found 7 (0.65%)
cell-cell conjugates with anti-Gag labelling at the VS
(Figure 1D,E,F, arrows). HTLV-1 particles were identified by
their close resemblance in size and morphology to the HTLV-1
particles produced by in vitro cell lines, described by Miyauchi et
al [19], and by positive staining for Gag protein; such particles
were not observed in uninfected cells or conjugates. Many HTLV-
1 particles were almost entirely surrounded by the adjacent cell
membranes (Figure 1D); others were contained in a larger synaptic
pocket (Figure 1E). In several cases, viral particles were in contact
with the two adjacent cell membranes simultaneously
(Figure 1D,F). Mitochondria frequently accumulated in the
infected cell in the vicinity of the VS (Movies S1, Movie S3,
Movie S6; Figure 2A,B), consistent with the polarization of the
MTOC to the VS [2,14,15] (Figure 1G, arrow pointing at
centriole), as seen at the immunological synapse [20–22].
Figure 1. Two-dimensional ultrastructure of the HTLV-1 virological synapse. A, B Low-magnification images of single CD4+ T cells and cell-
cell conjugates: A, naturally HTLV-1 infected CD4+ T cells (PBMCs); B, non-infected CD4+ T cells. Cell-cell conjugates were significantly more frequent
and larger among HTLV-1 infected cells. C, frequency of cell-cell conjugates (relative to the total cell population) with a given minimum interface
length. Membrane-membrane interfaces were measured on 2D images for HTLV-1 infected (black bars) and uninfected (grey bars) CD4+ T cells. Error
bars: 90% confidence interval. D–G, Electron micrographs showing virological synapses between naturally HTLV-1 infected CD4+ T cells and target
cells with different morphologies. Cells were labelled against the viral Gag p19 matrix protein and stained with DAB/HRP and OsO4. D–F, Darkly
stained HTLV-1 particles, using the anti-Gag p19 monoclonal antibody, are held in the gap between the conjugated cells (white arrows). The
enveloped particles are often touching one or both cell membranes. The virus transmission domain is usually surrounded by a peripheral adhesion
domain which is characterized by close membrane apposition (D,E). G, Continuous cell-cell contact with polarized microtubule organizing centre
(MTOC) as indicated by a centriole (black arrow) at the synapse (white arrow heads). Detail of image A. Scale bars: A, B 5000 nm, D 500 nm, E
200 nm, F, G 1000 nm.
doi:10.1371/journal.pone.0002251.g001
Virological Synapse Tomography
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the size of HTLV-1 virions
We used the tomographic data to measure the intermembrane
spacing in the VS and the diameter of HTLV-1 particles. Areas of
continuous and close apposition of the plasma membranes were
present at the cell-cell contact (Figure 3A,B). The membrane
spacing in the adhesion area in three synapses showed a
distribution with a strong peak at ,20 nm and an averaged
median value of 25.7 nm (Figure 3C). HTLV-1 particles derived
from naturally infected CD4
+ T cells (N=44) had a mean
diameter of 105 nm (range 62–173 nm) and a median of 108 nm
(Figure 3E,F). Particles derived from the MS9 cell line (N=151)
had a mean diameter of 126 nm (range 46–246 nm) and a median
of 124 nm (Figure 3D,F).
The three dimensional ultrastructure of the HTLV-1
virological synapse reveals the presence of virions in
intercellular synaptic clefts
Conjugates formed with naturally infected CD4
+ T cells
contained small numbers of isolated, cell-free virus particles
(Figure 3E and Movie S2). However, most HTLV-1 particles were
in contact with a cell membrane. We observed Gag staining
associated with both cell membranes in the synaptic cleft,
consistent with the transfer of viral protein from cell to cell
(Figure 3B). Successive tomogram slices (Figure 4F,G,H) showed
that HTLV-1 particles frequently touched both cell membranes at
the same time (see also Figure 4E and Movies S3, Movie S4,
Movie S5, Movie S6, Movie S7). These results suggest that the
virion can fuse with the recipient cell membrane before complete
detachment from the infected cell. We also found that virus
budding into a synaptic pocket was not limited to one location, but
occurred at different places (i.e. spatially separated synaptic
pockets) simultaneously in the same synapse (Figure 4A,B,C,
Movie S3). In contrast with these observations on naturally-
infected lymphocytes, VS formed between target cells and the
continuous HTLV-1-producer cell line MS9 [14] showed sites of
virus budding and abundant virus particles both inside the VS
(Figure 5A,B,C and Movies S8, S9), and more prominently at the
periphery, i.e. outside the synapse (Figure 3D, Figure 5A,D,E and
Movie S1).
Discussion
Exogenous retroviruses contain an envelope, derived from the
plasma membrane of the infected cell, which undergoes fusion
with the plasma membrane of the target cell mediated by the viral
surface glycoprotein Env. Like other retroviruses, HTLV-1
requires Env for infectivity, suggesting that HTLV-1 spreads
between cells as conventional enveloped particles. However,
HTLV-1 spreads directly between cells via an organized cell-cell
contact called a virological synapse [2]. Furthermore, cell-free
HTLV-1 particles are usually undetectable in the serum of
HTLV-1-infected subjects, and cell-free blood products are not
infectious. Our tomographic data reconcile these observations by
showing that enveloped HTLV-1 particles are present in an
intercellular synaptic cleft in the VS between naturally infected
lymphocytes which is characteristically bounded by the tightly
apposed membranes of the infected and target cells. In some cases,
the virus particle detaches from the infected cell before making
contact with the target cell (Figure 6B, bottom). More commonly,
however, virus particles were observed in contact with the infected
cell, with the target cell, or with both cells simultaneously
(Figure 6B, top). The continuously infected producer cell line,
MS9, also showed virions at the periphery of the synapse. These
particles may remain visible under EM because they fail to fuse
with the plasma membrane of the target cell. However, virtually
no HTLV-1 particles from naturally infected CD4
+ T cells were
found at the periphery of the VS (Figure 6C).
It was previously shown that HTLV-1 induces cell-cell fusion in
certain cell lines in vitro [23], raising the possibility that HTLV-1
material is transferred across cell-cell membrane bridges in vivo.
However, we did not observe fusion between the two cell
membranes themselves. Our results therefore favour the model
shown in Figure 6B. These results suggest that there is rapid
transfer of enveloped HTLV-1 particles from cell to cell across the
VS. The directional nature of the process is indicated by the
polarization of Gag protein [2,14,15] and the restriction of
budding and released virions to the cell-cell contact area in the VS
formed with naturally-infected cells.
Microtubule polarization in the IS [20] is triggered by
engagement of the T-cell receptor, whereas in the VS the
polarization is triggered by a synergistic interaction between the
Figure 2. Polarization of mitochondria and microtubule organization centre of the HTLV-1 infected cell towards the target cell. A,B
Virological synapses (VS) formed between naturally HTLV-1 infected CD4
+ T cells (PBMCs) and autologous uninfected CD4
+ target cells as shown in
Movies S6–S7 and S3, S4, S5, respectively. HTLV-1 particles in the synaptic cleft can be identified by the black anti-Gag p19 labelling (white arrow
heads). Mitochondria (black arrows) are located in the vicinity of the synapse; most mitochondria (black arrows) are polarized towards the VS. Also the
MTOC is polarized to the synapse as revealed by one of the two centrioles (white arrow in B). Scale bars: A and B 500 nm.
doi:10.1371/journal.pone.0002251.g002
Virological Synapse Tomography
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surface [14,15]. The differences between the VS and the IS are
extended here: whereas secretory lysosomes are secreted into a
single synaptic pocket in the cytotoxic synapse [21,22] (Figure 6A),
the tomographic data of the HTLV-1 VS (Figure 4C, Figure 6B)
demonstrated multiple, spatially distinct sites of virus budding into
synaptic pockets that are separated by areas of close membrane–
membrane apposition. These adhesion areas are characterized by
a membrane-membrane distance of ,20 nm (averaged median
value of 25.7 nm). This finding is consistent with previous
measurements of cell-cell separation between lymphocytes and
target cells [24], and with data on the conformation of ICAM-1/
LFA-1 binding from electron microscopy [25] and X-ray
crystallography [26]. The size of HTLV-1 particles that originate
from naturally infected CD4
+ T cells has a wide range (62 nm–
173 nm), similar to the variability in size of HIV-1 particles
[27,28], with a peak at about 100 nm. The size distribution of
particles derived from the MS9 cell line was similar but the mean
size of MS9-derived particles was slightly larger. Our results are
similar to previous measurements of HTLV-1 particles obtained
from two different cell lines [19].
Whereas most viruses spread by releasing large numbers of
virions from the infected cell, HTLV-1 uses the mobility of the
host cell to propagate from cell to cell. Other synapse-inducing
retroviruses such as HIV-1 [5,29] may use a similar mechanism of
viral transmission. Sequestration in the synaptic cleft presumably
allows efficient transfer of small numbers of virions, and may give
the virions a degree of protection from components of the immune
response (complement system and antibodies). We conclude that
the HTLV-1 VS allows efficient propagation of HTLV-1 by
triggered, directional transfer of enveloped virions directly from
cell to cell.
Materials and Methods
Naturally infected CD4
+ T cells
Peripheral blood mononuclear cells (PBMCs) were donated by
HTLV-1 seropositive patients with HTLV-1-associated myelopa-
thy/tropical spastic paraparesis (HAM/TSP) attending the
National Centre for Human Retrovirology at St Mary’s Hospital,
London.
We used samples from three different patients with HAM/TSP,
each with a high proviral load of HTLV-1: one sample was not
immunostained and the two others were stained with anti-Gag
antibody. We also used CD4
+ T-cells isolated from an HTLV-1
seronegative healthy donor as a negative control.
All patients gave written informed consent, and the study was
approved by the St Mary’s NHS Trust Local Research Ethics
Committee. The PBMCs were isolated by density gradient
centrifugation on Histopaque-1077 (Sigma-Aldrich Company
Ltd, Dorset, UK), washed twice with phosphate buffered saline
(PBS) and washed once in PBS/10% FCS. CD4
+ T cells were
negatively selected from the PBMCs using the CD4
+ T cell
isolation Kit from Miltenyi Biotech, Surrey, UK, following the
manufacturer’s instructions. This procedure yielded CD4
+ cells at
a purity of greater than 90%, ascertained by flow cytometry (data
not shown). Before use, the isolated CD4
+ T cells were cultured
overnight in 10 cm diameter tissue culture dishes (10
6 cells/ml), to
allow spontaneous expression of HTLV-1 proteins [30]. During
this incubation, the cells were widely dispersed to minimize cell-
cell contact. Before processing for EM the cells were gently
centrifuged for 5 minutes at 300 g to induce cell-cell conjugates
and then incubated for another 1 h at 37uC and 5% CO2.
T cells were cultured in RPMI 1640 medium (Sigma-Aldrich
Company Ltd, Dorset, UK) supplemented with 2 mM glutamine
Figure 3. VS membrane-membrane distances and HTLV-1 virion diameter. A, B Tomogram slices showing close membrane apposition in
the HTLV-1 virological synapse (VS) (black arrowheads): A, VS formed between an HTLV-1 infected MS9 cell as a donor and Jurkat cell as target. B,V S
formed between a CD4
+ T-cell naturally infected with HTLV-1 (PBMC) and an autologous uninfected CD4
+ as a target cell. These cells were stained
against HTLV-1 Gag p19 matrix protein with a specific monoclonal antibody (GIN7). The microtubule organizing centre is polarized to the synapse as
revealed by one of the two centrioles (black arrow). C, The spacings between those areas of the conjugated cell membranes that constitute the VS
were measured in three VS between naturally HTLV-1 infected CD4
+ T-cell (PBMC) and autologous uninfected CD4
+ as target cells: each distribution
shows a peak around 20 nm. D, Tomogram slice showing a large number of virus particles (examples indicated by black arrows) that budded from an
MS9 cell into the extra-cellular space. E, Tomogram slice showing virions (two examples indicated by black arrows) that budded from a naturally
HTLV-1 infected CD4
+ T-cell (PBMC) into the synaptic cleft. Most of these virions are not attached to a cell membrane. F, Distribution of diameter of
HTLV-1 virions from MS9 cells (dark grey) and naturally infected CD4
+ T cells (light grey): the distributions are slightly different with a median of
124 nm and 108 nm, respectively. Scale bars: A 1000 nm, B,D,E 500 nm.
doi:10.1371/journal.pone.0002251.g003
Virological Synapse Tomography
PLoS ONE | www.plosone.org 4 May 2008 | Volume 3 | Issue 5 | e2251Figure 4. Three-dimensional ultrastructure of the VS: enveloped HTLV-1 virions are trapped in multiple isolated synaptic clefts.
Cell-to-cell transmission of HTLV-1 as observed in tomograms of the VS formed between HTLV-1 infected CD4
+ T-cell (PBMC) and an autologous
uninfected CD4
+ T-cell as a target cell. These cells were stained against HTLV-1 Gag p19 matrix protein with a specific monoclonal antibody (GIN7). A,
B, Projections along the z-axis of two subvolumes of the same tomogram showing viral transmission at two different locations. C, Surface
representation of the VS shown in (A, B): Several virions (blue) are trapped between the closely apposed plasma membranes (yellow). D, Tomogram
slice showing an HTLV-1 particle held between the cell membranes. E, Surface representation of the virus transmission shown in D (cell membranes:
yellow and orange, virus envelope: blue, virus core: magenta). F, G, Tomogram slices through the two areas of virus transmission shown in (A) and
(B), respectively, with a spacing of about 17 nm (F) and 25 nm (G) between subsequent slices. Black arrows indicate a protrusion linking the virus
with the cell membrane. H, Subsequent slices through the area of virus transmission shown in (D) with a spacing of about 17 nm. Black arrows
indicate a protrusion linking the virus with the cell membrane. Scale bars: A,B 300 nm, D 500 nm, F,G 100 nm, H 200 nm.
doi:10.1371/journal.pone.0002251.g004
Virological Synapse Tomography
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Ltd, Paisley, UK), 100 IU/ml streptomycin (Invitrogen Ltd,
Paisley, UK) and 10% heat-inactivated fetal calf serum (PAA
Laboratories Ltd, Somerset, UK).
HTLV-1-immortalized cell line and Jurkat cell line
The HTLV-1- immortalized cell line, MS9 was a gift from Dr.
David Derse, National Cancer Institute, Maryland, USA. MS9
cells were derived by co-culture of phorbol-12- myristate-13-
acetate-activated human peripheral PBMCs with DBS-FRhL
(clone B5) cells that were infected with the HTLV-1 molecular
clone, pHTLV-X1MT [31]. MS9 cells were cultured in RPMI
1640 (Sigma-Aldrich Company Ltd, Dorset, UK) supplemented
with 2 mM glutamine (Invitrogen Ltd, Paisley, UK), 100 IU/ml
penicillin (Invitrogen Ltd, Paisley, UK), 100 IU/ml streptomycin
(Invitrogen Ltd, Paisley, UK), 20% heat-inactivated fetal calf
serum (PAA Laboratories Ltd, Somerset, UK) and 100 U/ml
recombinant interleukin 2 (IL-2; Sigma-Aldrich Company Ltd,
Dorset, UK). Jurkat cells (clone E6.1) were obtained from ATCC,
Middlesex, UK. Jurkat E6.1 is a clone of the Jurkat-FHCRC cell
line, a derivative of the Jurkat cell line [32]. Before processing for
EM and/or IFM the cells were mixed 1:1 with Jurkat cells and
incubated for 30 minutes at 37uC and 5% CO2 to induce cell-cell
conjugates.
Sample preparation for EM
Samples were prepared with different buffers and different
amounts of fixatives, depending on whether they were destined to
be immunostained with the mAb anti-Gag p19 (GIN7) or to be
stained with magnesium uranyl acetate (Sigma-Aldrich Company
Ltd, Dorset, UK). In general, the fixation of the samples was
performed sequentially in two distinct fixative solutions: Solution
A, 2% paraformaldehyde (PFA) (Electron Microscopy Science,
Hatfield, PA, USA) and 0.5% glutaraldehyde (Agar Scientific Ltd,
Figure 5. Tomogram slices and surface representations of the virological synapse between an HTLV-1 infected MS9 cell and a
target cell. A, The VS is characterized by a tight membrane-membrane contact with an inter-membrane spacing of about 20 nm. Viral budding sites
(black arrowheads) and virus particles (white arrowhead) can be detected within a synaptic pocket and at the periphery of the synapse formed
between HTLV-1 infected MS9 cell as a donor, and Jurkat cell as a target. B and D show slices through the synaptic cleft and the periphery,
respectively, as indicated by the white rectangles in (A), C and E show the corresponding surface representations (cell membranes: yellow, virus
envelope: blue, virus core: magenta, viral core protein at budding site: red). Scale bars: A 500 nm, B and C 200 nm.
doi:10.1371/journal.pone.0002251.g005
Virological Synapse Tomography
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Aldrich Ltd, Dorset, UK); and Solution B, 1% osmium tetroxide
(OsO4) in PBS (Sigma-Aldrich Ltd, Dorset, UK).
After incubating the samples to induce cell-cell conjugates, they
were pre-fixed in the 106 diluted PFA/glutaraldehyde (Solution
A) for 10 minutes before centrifugation. After centrifuging for
5 minutes at 1000 g the samples were fixed for another hour with
the undiluted fixative (Solution A). The samples were washed 3
times either with PBS 1% BSA or with sodium cacodylate buffer
0.1 M, pH 7.2, and then processed for antibody staining as
described below or post-fixed with 1% OsO4 (Solution B) and
stained in magnesium uranyl acetate overnight, respectively.
The fixed samples were dehydrated through a series of ethanol
exchanges and embedded in Agar 100 resin (Agar Scientific Ltd.,
Stansted, UK). The samples were baked at 60uC overnight to give
solid blocks that were sectioned with an ultramicrotome (Leica
Ultracut UCT, Leica Microsystems GmbH, Wetzlar, Germany) at
a thickness of 60–300 nm. Thin samples (60–100 nm) were floated
onto 200/300 mesh square Ni grids (Agar Scientific Ltd., Stansted,
UK). Thick samples for tomography (200–300 nm) were either
floated onto 200 mesh square Ni grids or onto formvar film coated
Cu 162 mm slot grids (Agar Scientific Ltd., Stansted, UK) to
allow for the collection of serial sections. Samples that were not
antibody labelled were stained with lead citrate (Leica Ultrostain2)
for 3–10 minutes, depending on the thickness of the sections, by
floating the grids on drops of the staining solution. For electron
tomography the grids were covered with 10 nm or 15 nm fiducial
gold beads (Sigma-Aldrich Company Ltd, Dorset, UK) to facilitate
image processing.
Pre-embedding antibody staining for EM
To detect HTLV-1 Gag matrix protein in infected cells the
samples were labelled against HTLV-1 Gag p19 [33] using the
DAB kit from Molecular Probes (Invitrogen Ltd, Paisley, UK ).
After the PFA/glutaraldehyde fixation, the samples were incubat-
ed in PBS containing 1% BSA, 0.1% Triton X-100 and 2% H2O2,
for 1 h at 37uC to block non-specific antibody binding and to
quench the endogenous peroxidase activity of the cells. To detect
the HTLV-1 complexes, the cells were incubated with 5 mg/ml of
anti-Gag p19 (GIN7 mAb) [33] diluted in PBS 1% BSA, for 1 h at
37uC. Then the second antibody, anti-Mouse mAb conjugated to
HRP (Invitrogen Ltd, Paisley, UK ), was added at a final dilution
of 1 mg/ml, and incubated for 30 minutes at 37uC. The cells were
washed three times with PBS containing 1% BSA between each
step.
The sample was centrifuged and embedded into a 1% agarose
gel (Sigma-Aldrich Ltd, Dorset, UK). A 1 mg/ml DAB solution
(Invitrogen Ltd, Paisley, UK ) diluted in PBS/1%BSA was added
to the samples and incubated for 15 minutes at room temperature
with gentle shaking. The staining was detected by adding to the
samples 0.03% H2O2 diluted in PBS/1%BSA. The samples
turned brown within 30 s to 5 min and the reaction was then
stopped by washing extensively with PBS. Between each
procedure the cells were centrifuged at 1000 g and washed
thoroughly at least three times in PBS. The samples were finally
fixed for at least 5 minutes in a 1% OsO4 solution (samples turned
black) and washed 5 times before further processing.
Electron microscopy, tomography, modelling and data
analysis
Electron microscopic data were collected with an FEI Tecnai
F30 FEG transmission electron microscope (FEG-TEM) (FEI
Company, Eindhoven, The Netherlands) at an electron voltage of
300 kV. The TEM was equipped with an energy filter (Gatan
imaging filter (GIF), Gatan, Inc., Abingdon, UK). Electron
micrographs were recorded using the software Digital Micrograph
(Gatan, Inc., Abingdon, UK) with a Gatan 2k62k slow-scan CCD
camera. Most tomographic data sets were recorded at a few
microns under focus using the GIF with a slit width of 20–25 eV to
accentuate contrast. Tilt series for tomography were recorded in
steps of 1u over a tilt range of typically 265u to +65u using the FEI
software. Most tomographic data sets were recorded using a flip-
flop sample holder (Gatan) that allows one to turn the sample by
90u inside the EM column. A few data sets were recorded in the
Laboratory for 3-Dimensional Electron Microscopy of Cells in
Boulder, Colorado with a FEI Tecnai F30 FEG-TEM (without
energy filter). These data were recorded using the software
SerialEM (Boulder, Colorado) with a Gatan CCD camera.
Tomograms were processed with the tomography software IMOD
[34] and surface representations were generated using both
Figure 6. Models of immunological and virological synapses. A, Upon formation of an IS between a cytotoxic T lymphocyte (CTL) and a
target cell the microtubule organizing centre is polarized towards the synapse (the centrioles are depicted as orange ellipses). Lytic granules
containing cytotoxins (red discs within CTL) are transported along microtubules (black lines) to the synaptic cleft. The cytotoxins (red points) are
released into the synaptic cleft and taken up by the target cell. B–C, Possible modes of viral transmission through the HTLV-1 virological synapse: B,
Enveloped HTLV-1 particles (purple-blue discs) bud into the synaptic cleft and are transmitted to the target cell. C, Enveloped virus particles bud at
the periphery of the synapse and are transmitted through the extracellular space.
doi:10.1371/journal.pone.0002251.g006
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Systems, Inc.). Data analysis was performed using IMOD,
AMIRA and Matlab (The MathWorks). Membrane-membrane
spacings were measured using a program that calculates the
distance between each voxel of the digitized membrane model
(surface representation) and its nearest neighbour in the opposite
cell membrane. The size of individual HTLV-1 particles was
determined by measuring an averaged diameter in the section
(through the 3D object) of largest appearance of the particle.
Supporting Information
Movie S1 Tomographic reconstruction showing a large number
of HTLV-1 particles of variable size in the space between a
chronically infected MS9 cell (top) and a potential Jurkat target
cell (bottom). The particles are characterized by an electron-dense
core surrounded by a less dense area and enveloped by the
electron-dense viral membrane. The average diameter of HTLV-1
particles derived from MS9 cells was 126.0 +/2 31.3 nm (SD).
White arrows indicate areas in the MS9 cell where viral capsid
protein accumulates below the membrane in anticipation of virus
budding. Three small parts of mitochondria (upper left corner) and
several microtubules are visible in the MS9 cell cytoplasm. A slice
through the entire tomogram is shown in Figure 3D. The sample
was fixed with PFA/glutaraldehyde, embedded in Agar 100 resin,
post-fixed with OsO4 and stained with lead citrate. The
reconstructed 3D volume is composed of tomograms obtained
from four serial sections. The tomograms were calculated from tilt
series of 121 images (tilt range 260u to +60u,1 u increment). The
images were recorded with a 2k62k Gatan CCD camera (pixel
size 1.21 nm) at an under focus of 20.2 mm with an FEI Tecnai
F30 FEG-TEM (300 kV) in Boulder, Colorado using the software
SerialEM. The reconstruction was calculated using the software
IMOD. The tomogram represents a volume with an area of
1.9461.28 mm2 and a thickness of 640 nm. The scale bar at the
end of the movie corresponds to 400 nm.
Found at: doi:10.1371/journal.pone.0002251.s001 (1.35 MB
MPG)
Movie S2 Tomographic reconstruction showing a few virus
particles that budded from a naturally HTLV-1 infected CD4+ T
cell (PBMC) into the synaptic cleft. Most of the virions are not
attached to a cell membrane. The particles are characterized by an
electron-dense core surrounded by a less dense area and enveloped
by the electron-dense viral membrane. The average diameter of
HTLV-1 particles derived from naturally HTLV-1 infected CD4+
T-cell (PBMC) was 105.2 +/2 21.8 nm (SD). A slice through the
entire tomogram is shown in Figure 3E. The sample was fixed with
PFA/glutaraldehyde, embedded in Agar 100 resin, post-fixed with
OsO4 and stained with lead citrate. The tomogram was calculated
from a tilt series of 141 images (tilt range 270u to +70u,1 u
increment). The images were recorded with a 2k62k Gatan CCD
camera (pixel size 1.21 nm) at an under focus of 20.2 mm with an
FEI Tecnai F30 FEG-TEM (300 kV) in Boulder, Colorado using
the software SerialEM. The reconstruction was calculated using
the software IMOD. The tomogram represents a volume with an
area of 1.7062.24 mm2 and a thickness of 176 nm.
Found at: doi:10.1371/journal.pone.0002251.s002 (8.45 MB
MPG)
Movie S3 Tomographic reconstruction showing the virological
synapse between a naturally HTLV-1-infected CD4+ T-cell
(PBMC) (right) and a target cell (autologous uninfected CD4+
T-cell) (left). Virus transmission can be seen in two separate
synaptic clefts. The HTLV-1 particles are in simultaneous contact
with the two cell membranes and are extremely electron-dense due
to the labelling of the viral Gag p19 matrix protein (see also
Movies S4 and S5). Parts of the two plasma membranes are also
darkly stained, indicating the presence of viral Gag protein. The
presence of two centrioles (long white arrows), two Golgi
apparatuses (short, thick white arrows) and several mitochondria
close to the VS reflects the polarization of the microtubule
organizing centre (MTOC) of the HTLV-1-infected CD4+ T cell
towards the cell-cell contact. Parts of the cell nucleus can be seen
in both cells. Tomogram slices through the 3D reconstruction can
be seen in Figure 4A,B and a surface representation of the synapse
is shown in Figure 4C. The sample was fixed with PFA/
glutaraldehyde, labelled against viral Gag p19 matrix protein,
embedded in Agar 100 resin and post-fixed with OsO4. The
reconstructed 3D volume is composed of tomograms obtained
from five serial sections. The tomograms were calculated from tilt
series of 131 images (tilt range 265u to +65u,1 u increment). The
images were recorded with a 2k62k Gatan CCD camera (pixel
size 1.29 nm) at an under focus of 23.0 mm with an FEI Tecnai
F30 FEG-TEM (300 kV) using the FEI software. The reconstruc-
tion was calculated using the software IMOD. The tomogram
represents a volume with an area of 1.5562.66 mm2 and a
thickness of 343 nm. The scale bar at the end of the movie
corresponds to 500 nm.
Found at: doi:10.1371/journal.pone.0002251.s003 (6.59 MB
MPG)
Movie S4 Detail of the tomographic reconstruction shown in
Movie S3 illustrating an HTLV-1 particle trapped between the
cell membranes. The enveloped virion touches both cell
membranes. Some dense material links the particle with the
target membrane (black area above the particle). See also
Figure 4D. For technical details see legend of Movie S3.
Found at: doi:10.1371/journal.pone.0002251.s004 (9.17 MB
MPG)
Movie S5 Detail of the tomographic reconstruction shown in
movie 3A illustrating HTLV-1 particles trapped between the cell
membranes. The enveloped virions touch both cell membranes.
See also Figure 4G. For technical details see legend of Movie S3.
Found at: doi:10.1371/journal.pone.0002251.s005 (6.84 MB
MPG)
Movie S6 Tomographic reconstruction showing the virological
synapse between a naturally HTLV-1-infected CD4+ T-cell
(bottom) and an autologous uninfected CD4+ T-cell cell, target
cell (top). A large HTLV-1 particle (black arrow) is held between
the two cell membranes and is extremely electron-dense due to the
labelling against viral Gag p19 matrix protein (see also Movie S7).
Parts of the two plasma membranes and inter-membrane material
are also darkly stained, indicating the presence of abundant viral
Gag protein. Several mitochondria have accumulated at the VS
within the HTLV-1-infected CD4+ T (PBMC) which is charac-
teristic of MTOC polarization, and is also seen in the IS. A
tomogram slice showing a larger area of the 3D reconstruction can
be seen in Figure 4D. The sample was fixed with PFA/
glutaraldehyde, labelled against viral Gag p19 matrix protein,
embedded in Agar 100 resin and post-fixed with OsO4. The
reconstructed 3D volume is composed of tomograms obtained
from five serial sections. The tomograms were calculated from tilt
series of typically 131 images (tilt range 265u to +65u,1 u
increment). The images were recorded with a 2k62k Gatan CCD
camera (pixel size 1.29 nm) at an under focus of 25.0 mm with an
FEI Tecnai F30 FEG-TEM (300 kV) using the FEI software. The
reconstruction was calculated using the software IMOD. The
tomogram represents a volume with an area of 2.2460.98 mm2
Virological Synapse Tomography
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corresponds to 500 nm.
Found at: doi:10.1371/journal.pone.0002251.s006 (4.18 MB
MPG)
Movie S7 Detail of the tomographic reconstruction shown in
Movie S6 illustrating an HTLV-1 particle held between the cell
membranes. The enveloped virion touches both cell membranes
simultaneously. Some dense material links the particle with the
target membrane (black area in the bottom right of the particle at
the end of the movie). See also Figure 4H. For technical details see
legend of Movie S6.
Found at: doi:10.1371/journal.pone.0002251.s007 (6.83 MB
MPG)
Movie S8 Tomographic reconstruction showing a synaptic cleft
formed between a chronically HTLV-1-infected MS9 cell (right)
and a target Jurkat cell (left). The synaptic cleft is completely
enclosed by a close membrane-membrane contact extending over
a large area with a diameter of about 6 mm (see Figure 3A and
Figure 5A). The membrane-membrane distance in areas of close
apposition is about 20 nm. Two HTLV-1 particles are in the
synaptic cleft (white arrowheads). White arrows indicate areas in
the MS9 cell where viral capsid protein has accumulated below the
membrane before directed virus budding. A tomogram slice
showing a larger area of the 3D reconstruction can be seen in
figure 5A. The sample was fixed with PFA/glutaraldehyde,
embedded in Agar 100 resin, post-fixed with OsO4 and stained
with lead citrate. The reconstructed 3D volume is composed of
tomograms obtained from two serial sections. The tomograms
were calculated from tilt series of typically 121 images (tilt range
260u to +60u,1 u degree increment). The images were recorded
with a 2k62k Gatan CCD camera (pixel size 1.54 nm) at an under
focus of 20.2 mm with an FEI Tecnai F30 FEG-TEM (300 kV) in
Boulder, Colorado using the software SerialEM. The reconstruc-
tion was calculated using the software IMOD. The tomogram
represents a volume with an area of 1.3261.92 mm2 and a
thickness of 326 nm. The scale bar at the end of the movie
corresponds to 500 nm.
Found at: doi:10.1371/journal.pone.0002251.s008 (2.09 MB
MPG)
Movie S9 Surface representation of the synaptic cleft between a
chronically HTLV-1-infected MS9 cell and a Jurkat target cell
shown in tomogram 5a. The cell membranes are depicted in
yellow and HTLV-1 particles in blue. The red areas represent
membrane segments within the MS9 cell where viral capsid
protein has accumulated in anticipation of directed virus budding.
The surface representation was generated using the software
packages IMOD and AMIRA.
Found at: doi:10.1371/journal.pone.0002251.s009 (9.80 MB
MPG)
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